Search research articles
Contact Us
Filters
Showing results (91-100 of 113) with videos related to
Page
of 12
Sort By:
Blood
|
April 18, 2024
Real-world and clinical trial outcomes in large B-cell lymphoma with axicabtagene ciloleucel across race and ethnicity
Frederick L Locke, Tanya Siddiqi, Caron A Jacobson, et al.
Blood Advances
|
January 7, 2026
Spectrum, prevalence, and clinical correlates of PPM1D mutations in patients with clonal hematopoiesis and clonal cytopenias
Talha Badar, Ludovica Marando, Eric Latorre-Crespo, et al.
European Journal of Haematology
|
May 11, 2021
Intensive induction regimens after deferring initial therapy for mantle cell lymphoma are not associated with improved survival
Krithika Shanmugasundaram, Subir Goyal, Jeffery Switchenko, et al.
Blood Cancer Journal
|
August 14, 2025
Clinical and molecular characterization of TP53-mutant acute lymphoblastic leukemia in adults
Ethan J Harris, Diren Arda Karaoglu, Madina Sukhanova, et al.
Blood Advances
|
September 13, 2021
Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy
David A Bond, Jeffrey M Switchenko, Diego Villa, et al.
Cancer
|
September 23, 2020
African Americans with translocation t(11;14) have superior survival after autologous hematopoietic cell transplantation for multiple myeloma in comparison with Whites in the United States
Talha Badar, Parameswaran Hari, Omar Dávila, et al.
American Journal of Hematology
|
December 13, 2024
Mayo Genetic Risk Models for Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax + Hypomethylating Agent
Naseema Gangat, Azeem Elbeih, Nour Ghosoun, et al.
Blood Advances
|
March 14, 2025
Evidence-based risk stratification of myeloid neoplasms harboring TP53 mutations
Mithun Vinod Shah, Kevin Hung, Anmol Baranwal, et al.
Blood
|
June 2, 2026
Ziftomenib with venetoclax and azacitidine in relapsed/refractory NPM1-mutated acute myeloid leukemia
Eunice S Wang, Harry P Erba, Amer M Zeidan, et al.
Blood Cancer Journal
|
May 7, 2025
Validation of the 5th edition of the World Health Organization and International Consensus Classification guidelines for TP53-mutated myeloid neoplasm in an independent international cohort
Mithun Vinod Shah, Kevin Hung, Anmol Baranwal, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 113) with videos related to
Sort By:
Page
of 12
Blood
|
April 18, 2024
Real-world and clinical trial outcomes in large B-cell lymphoma with axicabtagene ciloleucel across race and ethnicity
Frederick L Locke, Tanya Siddiqi, Caron A Jacobson, et al.
Blood Advances
|
January 7, 2026
Spectrum, prevalence, and clinical correlates of PPM1D mutations in patients with clonal hematopoiesis and clonal cytopenias
Talha Badar, Ludovica Marando, Eric Latorre-Crespo, et al.
European Journal of Haematology
|
May 11, 2021
Intensive induction regimens after deferring initial therapy for mantle cell lymphoma are not associated with improved survival
Krithika Shanmugasundaram, Subir Goyal, Jeffery Switchenko, et al.
Blood Cancer Journal
|
August 14, 2025
Clinical and molecular characterization of TP53-mutant acute lymphoblastic leukemia in adults
Ethan J Harris, Diren Arda Karaoglu, Madina Sukhanova, et al.
Blood Advances
|
September 13, 2021
Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy
David A Bond, Jeffrey M Switchenko, Diego Villa, et al.
Cancer
|
September 23, 2020
African Americans with translocation t(11;14) have superior survival after autologous hematopoietic cell transplantation for multiple myeloma in comparison with Whites in the United States
Talha Badar, Parameswaran Hari, Omar Dávila, et al.
American Journal of Hematology
|
December 13, 2024
Mayo Genetic Risk Models for Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax + Hypomethylating Agent
Naseema Gangat, Azeem Elbeih, Nour Ghosoun, et al.
Blood Advances
|
March 14, 2025
Evidence-based risk stratification of myeloid neoplasms harboring TP53 mutations
Mithun Vinod Shah, Kevin Hung, Anmol Baranwal, et al.
Blood
|
June 2, 2026
Ziftomenib with venetoclax and azacitidine in relapsed/refractory NPM1-mutated acute myeloid leukemia
Eunice S Wang, Harry P Erba, Amer M Zeidan, et al.
Blood Cancer Journal
|
May 7, 2025
Validation of the 5th edition of the World Health Organization and International Consensus Classification guidelines for TP53-mutated myeloid neoplasm in an independent international cohort
Mithun Vinod Shah, Kevin Hung, Anmol Baranwal, et al.
Page
of 12